In response to these worrying signs, the dis course on HIV prevention at the Toronto con ference focused on the recently coined notion of "prevention technologies" which, while not including behaviour change, does include cer vical barriers, pre-exposure prophylaxis with with discourses now dominating the interna tional HIV/AIDS field that favour medical inter vention and morally sanctioned control over community mobilisation and activism for estab lishing and sustaining changes in behaviour. The USA, particularly under the current administra tion, has shifted the agenda in the direction of achieving its moral ends, and has pushed the longer-term collective memory of HIV preven tion successes otherwise achieved out of the spotlight. The fact that each of these "preven tion technologies" ultimately relies on human behaviour -putting on the condoms, inserting the microbicides, taking the pills, deciding to fund a programme of herpes suppression -seems not to be noticed.
The enthusiastic support for male circumci sion in Toronto was not based solely on com pleted scientific studies. It was based, too, on enthusiasm for the potential findings from two randomised clinical trials (RCTs)t then underway in Rakai, Uganda, and Kisumu, Kenya, and on longstanding recognition of a relation between male circumcision and HIV prevalence. The trials in question were being undertaken following find ings from observational studies that noted in some places (but not everywhere) an associa tion between higher rates of male circumcision and lower HIV prevalence,3"6 from systematic reviews of the literature on circumcision,7'8 and from an earlier trial in Orange Farm in South Africa that found a partially protective effect of 61?/o.9 Preliminary findings from the subsequent trials in Uganda and Kenya were reported after they were stopped early by their respective Data Safety and Monitoring Boards in December 2006, as these trials were reporting interim efficacy findings of 48% (Uganda) and 53% (Kenya), and it would have been unethical to continue.
However, the rhetoric coming from the Toronto conference in August 2006 suggested that it was simply a procedural nicety to have to wait for the evidence from these trials. Not all Toronto conferees shared the euphoria, of course. Many were less sanguine, and for a variety of reasons. Just how is male circumcision talked about?
Part of the dilemma in understanding how male circumcision comes to figure in HIV/AIDS dis cussions can be gleaned from the confusing way the practice is talked about. Looking at the popu lar press, statements from AIDS celebrities and online discussion groups, we note that some pro ponents speak of male circumcision in terms of a "one-time intervention" offering "life-time pro tection", while others frame it as an "irreversible procedure" with only "partial protection". This "prevention technology" can be con trasted to an "historical and cultural practice". Several UNAIDS documents refer to "thorny issues" surrounding male circumcision and its What are the outcome patterns in the evidence so far? First, there is some evidence of a "pos sible anatomical explanation for the epidemio logically observed protective effect of male circumcision",24 concerning the susceptibility to HIV in Langerhans cells in the inner foreskin,25 and a protective keratinisation that occurs after circumcision. Yet, Langerhans cells occur in the clitoris, the labia and in other parts of both male and female genitals, and no one is talking of removing these in the name of HIV prevention.
Moreover, there is not full agreement on this par ticular argument about susceptibility.26 Also, at the Montreux meeting, it was pointed out that how keratinisation might work to provide a pro tective effect was actually unclear, and that more evidence is needed to support this idea, however plausible it appears. Second, the observational studies and sys tematic reviews cited above do not discuss places where HIV prevalence is low in non-or The African trials noted a partially protective effect, with efficacy somewhere in the order of 50-60% (South Africa 61%, Kenya 51%, Uganda 53% -an average of 55% using a modified What is important to remember is that, while the outcomes observed in these various studies certainly provide evidence of patterns, and the trials have confirmed the efficacy of the surgery, together these do not form the only generative mechanisms in developing effective programmes in real world settings -additional contributors will be involved too.
Putting male circumcision in context
The discussion above begins to reckon with the notion of social and contextual factors and dynamics, and how these play out in research, whether they are controlled for or not. This leads to a discussion of the more complex question of the potential social impact of increased male circumcision beyond individual medical indica tion to population health intervention.
"Interventions, by definition, are always inserted into pre-existing conditions... Programme sub jects are always faced with a choice, but it is both a limited and a loaded one. Programmes are met with constrained choices, located in pre existing conditions, and these, as well as the processes internal to the intervention, determine the balance between winners and losers."11 (p. 25) Understanding behavioural shifts is particu larly difficult. For example, in a recently reported Kenyan prospective study,35 behaviour change among circumcised men appeared to be quite volatile, in this case moving from higher levels of risk behaviour pre-circumcision, to excellent immediate post-operative compliance, followed by a return to the same levels of risky behaviour as uncircumcised men within the year after cir cumcision. While these researchers suggest that equality at one year provides no evidence of risk compensation, the large shifts in behaviour over a 15-month period might also suggest considerable capacity for behavioural variation in response to social forces or pressures. Some commentators note that it will be impor tant to frame any adoption of male circumcision within existing or proposed policies on sexual and 
Other contextual issues
There are a series of other social and contextual issues that will vex the global effort in pre vention, given that the pandemic is not under control. The first of these is traditional male cir cumcision, whether religious or ritual, e.g. coming of age.
Traditional male circumcision is common in some parts of Africa,39'40 and is not without its difficulties, including being implicated in HIV transmission itself.41'42 Traditional circumcision practices are themselves changing all the time, while retaining their symbolic meanings. Many of these may not readily transfer to a fully medi calised version of circumcision, and quite dif ferent processes may be needed than those in the trials. Maximising safety in traditional practices is not dissimilar to ensuring safety in other social practices involving a significant HIV risk, e.g. tattooing or scarification, for which there is a good deal of experience and guidance.
The WHO/UNAIDS Statement implies that intro ducing medical male circumcision in areas of high Were the trials themselves responsible or is there an increase in the acceptability of male circum cision that has its drivers elsewhere?46'47 What was being talked about outside the research settings and by whom? There have been dangerous examples of inac curate lay information and specious ideas about HIV/AIDS before, e.g. HIV does not cause AIDS, sex with a virgin will cure you, lemon juice douches can prevent infection (all untrue), and so on. How can the actual findings be separated from the global chatter that is happening and avoid significant distortions and claims being made? This discourse will need to be managed by the global HIV/AIDS community and the UN system, as well as national authorities and local non-governmental organisations. If not, decisions about circumcision, by individuals or by governments, may be taken without real know ledge of the pros and cons, the applicability to a country's particular epidemic, real-world effective ness versus efficacy, and the dangers, benefits and opportunity costs of widespread implementation.
There are also broader sexuality issues to be addressed, and these have almost been ignored in the discourse surrounding male circumcision. What about men who are sexually active with both men and women: how might they and their partners respond to circumcision and to the differential infectiousness of vaginal and anal intercourse? Yet here, anyone familiar with gay men's communities and other MSM subcultures knows that there is no one global idea of what it is to live as a gay man or to pursue sex with men in other realities. The diversity of these sexual cultures is well beyond current knowledge, and any circumcision trials mooted for USA gay men or in one or two developing countries will pro duce barely applicable evidence in relation to these populations.
Beyond these questions lies the vexed issue of setting a minimum age for circumcision to occur. The earlier in life that the procedure is done, the simpler and safer it can be compared with later age surgery. However, the human rights and ethical issues surrounding neonatal cir cumcision are quite difficult. Optimally, it should occur before the onset of sexual activity, thus avoiding early infection and early infection of others. This might require a minimum age of 10-15. Leaving it to age 18, e.g. for consent reasons, may be too late in some settings, but it is the current age of majority in many countries. Is there enough evidence to proceed?
We believe we need to know much more about male circumcision for HIV prevention before adopting it as a population health measure. The WHO/UNAIDS Statement is cautious in noting the existence of caveats and gaps, but it argues that it is time to go ahead. We would argue that there is still much work to do before national authorities and the global HIV/AIDS community can feel confident about proceeding.
The whole question of the acceptability of the procedure to individual men, to communities and to governments is more complex than has been assessed so far. The Orange Farm researchers reported that "70?/o of uncircumcised males will accept to be circumcised if MC reduces the risk of getting HIV".50 But as has been learned with HIV testing, while the idea of being tested may be acceptable, it often does not translate into actively seeking a test.51
A different kind of monitoring and evaluation process is needed, with a focus on the longer term social and cultural impact of introducing male circumcision as a population health inter vention, including on gender equity, something more than medico-behavioural methods tend to use. Medical researchers do not usually have the research design skills or theoretical exper tise to conceptualise these issues and to design instruments for such evaluation and monitor ing. The controversial nature of this irreversible surgical intervention on otherwise healthy bodies for longer-term, population-level effects demands high standards in this regard. We recognise that many of those advocating rapid implementation of male circumcision are motivated by a deep desire to halt this pandemic, yet so too are those of us, similarly motivated, who are wary of the indecent haste with which the discussion about male circumcision has been swept up in a tide of enthusiasm based on only one, albeit significant, part of the evidence base needed for recommending such a radical public health initiative. This is partly a "means and ends" discussion: do the ends justify the means? It is also a "ways and means" discussion: how is this At the moment, the enthusiasm for male cir cumcision is proffered to displace the disappoint ment of previous "silver" or "magic" bullets that have not worked as well as we had hoped. It is a dreadful pandemic, to be sure; but that does not mean we should lose sight of the fact that care, judgement, experience and knowledge are required before action. Evidence is but one form of this, and the determination not to harm others through haste or expedience must prevail.
